GlassScriptPhysician profile
Katherine Baker
NPI 1366687204
$1,925.18
in general payments reported to CMS, 2019-2025
12 companies · $333 in 2025
The $333 reported for 2025 was more than what 87% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $17.12 · 2022: $796 · 2023: $468 · 2024: $311 · 2025: $333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,112.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Y-Mabs Therapeutics, INC. | $1,047.75 | 2022-2025 | Danyelza |
| Sobi, INC | $245.89 | 2022-2024 | |
| Genzyme Corporation | $137.16 | 2023-2025 | |
| Verrica Pharmaceuticals INC. | $125.00 | 2023 | Ycanth |
| Jazz Pharmaceuticals INC. | $103.99 | 2022-2024 | |
| Servier Pharmaceuticals LLC | $67.76 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $51.69 | 2021-2024 | |
| Alexion Pharmaceuticals, INC. | $49.08 | 2023-2024 | Ultomiris |
| Rare Disease Therapeutics, INC. | $36.06 | 2024-2025 | Purixan |
| Pharming Healthcare, INC. | $26.14 | 2023 | Ruconest |
| Bayer Healthcare Pharmaceuticals INC. | $20.27 | 2025 | |
| Chiesi USA, INC. | $14.39 | 2024 | Ferriprox |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.